Contact   |   Login
Human Pharmaceuticals Banner Image

Human Pharmaceuticals

Pharmapex’s Human Pharmaceuticals Department (HPD) is a leading source for high-quality Active Pharmaceutical Ingredients (APIs) and Finished Pharmaceutical Products (FPPs) in various markets across the globe. With an extensive product portfolio, our group of companies is dedicated to addressing and solving the most important medical needs of our time, including oncology (e.g., multiple myeloma and prostate cancer), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes)†. Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency.

A. Active Pharmaceutical Ingredients (APIs):

B. Finished Pharmaceutical Products (FPPs):





† Not all products referred to on this site are available in all countries and our products are subject to different regulatory requirements depending on the country of use. Consequently, certain sections of this site may be indicated as being intended only for users in specific countries. Some of the products may also be marketed under different trade names.

You should not construe anything on this site as a promotion or solicitation for any product or for the use of any product that is not authorized by the laws and regulations of your country of residence. For inquiries about the availability of any specific product in your country, you may simply contact us at humanpharma@PharmapexUSA.com.

*Products currently covered by valid US Patents may be offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.



Quick Contact

Recent Newsletters:

Issue #: 211 – AHD:
by Animal Health Department

Issue #: 214 – CHD:
by Consumer Health Department

Issue #: 224 – F&F:
by Food & Feed Business Unit
Press Releases and Latest News:
PND releases a 200+ page catalog for 2016
Pharmapex's Nutrition Department releases an extensive 2016 catalog for dietary supplements.
Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.
FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© 2017, Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.